En Ossium, creemos que la ciencia es la mejor arma de la humanidad en la lucha contra las enfermedades, y aceptamos el reto de movilizar el ecosistema sanitario mundial para ganar esa lucha. En pos de este objetivo, capacitamos a nuestros empleados, mantenemos los más altos niveles de excelencia y somos una fuerza del bien.
Consejero Delegado, Cofundador y Presidente
Recovery Services
Estos expertos en recuperación de tejidos de donantes trabajan con nuestros socios OPO para mejorar continuamente nuestros procesos de recuperación de tejidos. Dominan los protocolos y prácticas de recuperación de Ossium.
Clinical Production
Estos expertos en procesamiento elaboran nuestros productos de terapia celular. Son expertos en procesamiento de tejidos, procesamiento celular y crioconservación.
Clinical
These clinical trial experts advance our clinical program by designing and implementing study protocols, managing research sites, and analyzing clinical trial data. Their work is critical in navigating the complex process of bringing innovative, life-saving treatments to patients in support of Ossium’s mission to improve the health, vitality, and longevity of human beings through bioengineering.
Quality Assurance
These Quality Assurance experts play a crucial role in preventing, detecting, and correcting defects and errors, fostering trust among patients and customers. They develop robust systems that ensure processes and products consistently meet established regulations and standards.
En un principio, me atrajo de Ossium la visión de Kevin de cambiar la forma en que pensamos sobre la asistencia sanitaria y el potencial de influir positivamente en tantas personas. A medida que fui conociendo al equipo, mi deseo de formar parte de Ossium no hizo más que crecer. Cada día vengo a trabajar lleno de energía por la pasión y los conocimientos de los que me rodean.
Vicepresidente de Personas y Talento
Vicepresidente de Personas y Talento
Ms. Gardner is a hands-on People leader with deep experience supporting high-growth startups across SaaS, cleantech, and fintech. Her focus is building scalable People and Talent infrastructure that emphasizes connection and engagement across multiple locations, teams, and levels. Ms. Gardner leads the People function at Ossium, which includes talent acquisition and development, compensation and benefits, as well as employee engagement and performance.
Before joining Ossium, Ms. Gardner established the People team as employee #18 at Turntide Technologies, a cleantech electric motor startup with backing from Jeff Bezos, Bill Gates, and Robert Downey Jr. During her tenure, she cemented the People team as the connective tissue for a before-its-time hybrid model of 6 offices and 40% remote staff, and drove 555% headcount growth across the company. At Turntide, she rolled out multiple people-focused initiatives including introducing OKRs, creating a recruiting playbook, founding a DEBI (Diversity, Equity, Belonging, & Inclusion) team, and building out the onboarding program, Turntide 101. Ms. Gardner also spent 4 years in HR consulting, working with startups across the nation to implement HR systems and best practices. Her team simultaneously supported between 30-40 clients to onboard companies’ first hires, create a foundational HR base, and set the company up for future success with a focus on proactive and consultative HR.
Prior to finding her calling in the People space, Ms. Gardner worked at San Francisco’s two science museums: the California Academy of Sciences (where she presented public engagement shows underwater as a scuba diver) and the Exploratorium. Ms. Gardner received her BA in Feminist Studies from Stanford University, where she won a national championship as a member of the women’s water polo team and was named to the All-American team all four years. She also spent six months playing professional water polo in Greece.
Aprecio mucho que Ossium me haya planteado retos que me han sacado totalmente de mi zona de confort. Es un lugar maravilloso para aprender y crecer.
Vicepresidente de Investigación
Vicepresidente de Investigación
For the past 20 years, Dr. Johnstone has been actively involved in translating adult stem cell therapies into treatments for a host of diseases affecting the major organs of the body. In 2004, he co-authored one of the first studies demonstrating the potential for treating cardiovascular diseases with novel adult stem cells isolated from fat. At Ossium, Dr. Johnstone leads the Research organization, driving innovation and translating scientific discoveries into practical applications that advance the company mission.
Dr. Johnstone co-founded NeuroFx, an early-stage biotech firm developing a novel therapy for neurological disorders. Dr. Johnstone led the R&D program at NeuroFx for two years, where he was directly responsible for preclinical and chemistry, manufacturing, and controls development activities. He continues to act as an advisor for NeuroFx. Additionally, Dr. Johnstone has formed two other biotech companies: Chemigen, which is developing a small molecule drug for treating Lou Gehrig’s disease, and EmphyMab Biotech (now Allinaire), which is developing biologics to treat serious lung diseases.
Before becoming an entrepreneur, Dr. Johnstone was an early employee at Sangamo Biosciences for 6 years. During this time, he managed the preclinical development program for their lead gene therapy candidate for cardiovascular diseases, which was promoted to clinical testing. Dr. Johnstone received his PhD from the University of Maryland, College Park, and completed a postdoctoral fellowship at the University of California, Los Angeles.
I was introduced to Ossium early on while working at an OPO, and I was immediately drawn to the mission and the groundbreaking work. Even now, I remain consistently impressed by the impactful work we do daily and am in awe of the exceptional expertise and dedication of my colleagues.
Director Asociado, Cumplimiento de Donaciones
Director Asociado, Cumplimiento de Donaciones
En Ossium, siempre estamos buscando personas con talento y motivadas por su misión.
